During the past decade, Michael Schaefers und Partner conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Michael Schaefers und Partner" are "Chronic Lymphocytic Leukemia" (2 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Michael Schaefers und Partner" in a lesser frequency.

Most popular intervention types in "Michael Schaefers und Partner" are "Drug" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "cytarabine" (2 trials), "etoposide" (2 trials), "filgrastim" (2 trials) and "peripheral blood stem cell transplantation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Michael Schaefers und Partner" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Michael Schaefers und Partner". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Michael Schaefers und Partner, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michael Schaefers und Partner, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".